Fennec Pharmaceuticals (FENC) Revenue (2020 - 2026)

Fennec Pharmaceuticals (FENC) has 4 years of Revenue data on file, last reported at $13.8 million in Q4 2025.

• Quarterly Revenue rose 73.84% year-over-year to $13.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $44.6 million (down 6.09% YoY) and the FY2025 annual result came in at $44.6 million, down 6.09% from the prior year.
• Revenue improved to $13.8 million in Q4 2025, from $12.5 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $25.4 million in Q1 2024 to a low of $1.7 million in Q1 2023.
• A 3-year average of $9.5 million and a median of $8.3 million in 2024 frame the typical range for Revenue.
• Annual changes were most pronounced in 2024 — Revenue jumped 1413.24% — and 2025, when it plunged 65.52%.
• Tracing FENC's Revenue over 3 years: stood at $9.7 million in 2023, then decreased by 18.59% to $7.9 million in 2024, then jumped by 73.84% to $13.8 million in 2025.
• The last three Revenue figures came in at $13.8 million (Q4 2025), $12.5 million (Q3 2025), and $9.7 million (Q2 2025), per Business Quant data.